Join our Newsletter — 33% off our NHI Course

What breaks when teams use generic zero-trust controls for clinical AI agents?

Generic zero-trust patterns often assume containment can happen without operational consequences. In healthcare, that assumption fails when the agent is mid-encounter or driving a clinical workflow, so teams need tiered enforcement and break-glass-aware response logic instead of a one-size-fits-all kill strategy.

Why This Matters for Security Teams

Clinical AI agents are not ordinary applications. They can assemble context, call tools, query records, and influence care workflows in real time. Generic zero-trust controls often treat those actions as interchangeable with any other workload, but healthcare creates a harder constraint: interruption can affect diagnosis, medication timing, triage, and documentation integrity. The risk is not only unauthorised access, but unsafe denial, delayed escalation, or a partial failure that leaves the agent and the clinician with inconsistent state.

This is why practitioners should read zero-trust through the lens of operational safety, not just access control. The NIST SP 800-207 Zero Trust Architecture model is useful for authentication, policy enforcement, and segmentation, but it does not by itself define how to handle a clinical agent that is mid-action and bound to a patient workflow. Current guidance suggests pairing zero-trust policy with AI-specific governance from the NIST AI Risk Management Framework so risk decisions account for context, impact, and fallback behaviour.

In practice, many security teams encounter the failure only after a blocked tool call interrupts care, rather than through intentional testing of clinical failure modes.

How It Works in Practice

For clinical AI agents, the control problem is not simply “allow or deny”. It is deciding what the agent may do, when it may do it, and what should happen if confidence, context, or policy changes mid-execution. The strongest implementations use tiered enforcement, where low-risk actions such as draft generation or summarisation are treated differently from higher-risk actions such as order entry, chart modification, or external communication. That tiering should be explicit, tested, and linked to the clinical workflow, not improvised during an incident.

Security teams should design policy around the agent’s operational state. For example, an agent that is supporting triage may need read-only fallback mode rather than a hard stop. An agent that is about to execute a tool action may require step-up approval, scoped delegation, or a human confirmation point. This is where agentic AI guidance becomes relevant. The OWASP Top 10 for Agentic Applications 2026 and the OWASP Agentic AI Top 10 both help frame failures such as excessive agency, tool misuse, and weak action boundaries. Threat modelling with the MITRE ATLAS adversarial AI threat matrix is also useful when the concern includes prompt injection, tool hijacking, or workflow manipulation.

  • Classify agent actions by clinical impact, not just by system sensitivity.
  • Separate identity proof, policy decision, and execution authority.
  • Define safe fallback states for read-only, pause, defer, and break-glass paths.
  • Log the reason for containment so reviewers can distinguish attack response from safety interruption.

Where teams fail, they usually collapse all of these steps into one global control plane and then discover that the control is too blunt for live clinical operations. These controls tend to break down when the agent has delegated tool access across multiple EHR, messaging, and scheduling systems because policy decisions lose context across system boundaries.

Common Variations and Edge Cases

Tighter containment often increases operational overhead, requiring organisations to balance patient safety, workflow continuity, and auditability against the desire for uniform enforcement. Best practice is evolving here, and there is no universal standard for this yet, especially when agents perform partial clinical tasks that straddle administrative and care-delivery functions.

One common edge case is break-glass access. In healthcare, a hard block may be safer for an untrusted consumer app, but it can be unacceptable for an agent assisting a clinician during an urgent event. That does not mean the agent gets unrestricted access. It means the response should be state-aware, time-bounded, and fully logged, with post-event review. Another edge case is model drift or tool-change drift: a zero-trust policy that was safe during pilot deployment may become brittle after the agent gains a new integration, a new prompt chain, or a new data source.

Clinical environments also need to separate identity and autonomy concerns. Human access policy alone does not govern agent behaviour, because an authenticated clinician may still authorize a workflow that the agent should not execute automatically. For that reason, alignment with NIST AI Risk Management Framework is important for governance, while NIST SP 800-207 Zero Trust Architecture remains the technical baseline for segmentation and verification. In healthcare, the practical question is not whether to block the agent, but whether the block preserves clinical safety when timing matters most.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

OWASP Agentic AI Top 10 and MITRE ATLAS address the attack and risk surface, while NIST CSF 2.0, NIST Zero Trust (SP 800-207) and NIST AI RMF set the governance and control requirements practitioners need to meet.

Framework Control / Reference Relevance
NIST CSF 2.0 PR.AC-1 Zero-trust enforcement depends on strong identity and access governance for agent actions.
NIST Zero Trust (SP 800-207) PL-2 Zero trust policy design is central to deciding how clinical agents are segmented and contained.
NIST AI RMF GOVERN Clinical AI needs governance that accounts for safety, context, and fallback risk.
OWASP Agentic AI Top 10 A01 Excessive agency is a core failure mode when generic controls overreach or under-specify action bounds.
MITRE ATLAS AML.T0020 Prompt injection and workflow manipulation are relevant threats to clinical AI agents.

Assign ownership, escalation logic, and review processes for safety-impacting agent decisions.